Rapid identification of mycobacteria and drug-resistant Mycobacterium tuberculosis by use of a single multiplex PCR and DNA sequencing

Journal of Clinical Microbiology

Volumn 50, Issue 2, 2012, Pages 326-336

  Pérez Osorio, Ailyn C ^a   Boyle, David S ^b   Ingham, Zachary K ^a   Ostash, Alla ^a   Gautom, Romesh K ^a   Colombel, Craig ^a   Houze, Yolanda ^a   Leader, Brandon T ^a  

^a Washington State Public Health Laboratories (WA PHL)   (United States)

^b Program for Appropriate Technology in Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; RNA 16S;

ACID FAST BACTERIUM; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; DNA SEQUENCE; DRUG RESISTANT TUBERCULOSIS; GENE AMPLIFICATION; GENE TARGETING; HSP65 GENE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MULTIPLEX POLYMERASE CHAIN REACTION; MYCOBACTERIAL IDENTIFICATION AND DRUG RESISTANCE SCREEN; MYCOBACTERIUM INTRACELLULARE AVIUM; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

ANTITUBERCULAR AGENTS; DNA, BACTERIAL; DNA, RIBOSOMAL; DRUG RESISTANCE, BACTERIAL; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; MULTIPLEX POLYMERASE CHAIN REACTION; MYCOBACTERIUM TUBERCULOSIS; RNA, RIBOSOMAL, 16S; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS, DNA; TUBERCULOSIS, MULTIDRUG-RESISTANT;

BACTERIA (MICROORGANISMS); CORYNEBACTERINEAE; MYCOBACTERIUM TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS COMPLEX;

EID: 84856143548     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.05570-11     Document Type: Article

References (76)

1. Aberer E, Bergmann AR, Derler AM, Schmidt B. 2007. Course of Borrelia burgdorferi DNA shedding in urine after treatment. Acta Derm. Venereol. 87:39-42. (Pubitemid 46225389)
2. Amicosante M, et al. 1995. Inactivation of polymerase inhibitors for Mycobacterium tuberculosis DNA amplification in sputum by using capture resin. J. Clin. Microbiol. 33:629-630.
3. Baron S. 1996. Medical microbiology, 4th ed. University of Texas Medical Branch at Galveston, Galveston, TX.
4. Boehme CC, et al. 2010. Rapid molecular detection of tuberculosis and rifampin resistance. N. Engl. J. Med. 363:1005-1015.
5. Brosch R, et al. 2002. A new evolutionary scenario for the Mycobacterium tuberculosis complex. Proc. Natl. Acad. Sci. U. S. A. 99:3684-3689. (Pubitemid 34252166)
6. Campbell PJ, et al. 2011. Molecular detection of mutations associated with first and second-line drug resistance compared with conventional drug susceptibility testing in M. tuberculosis. Antimicrob. Agents Chemother. 55:2032-2041.
7. Centers for Disease Control and Prevention. 2010. Decrease in reported tuberculosis cases - United States, 2009. MMWR Morb. Mortal. Wkly. Rep. 59:289-294.
8. Centers for Disease Control and Prevention. 1990. Nosocomial transmission of multidrug-resistant tuberculosis to health-care workers and HIV-infected patients in an urban hospital - Florida. MMWR Morb. Mortal. Wkly. Rep. 39:718-722.
9. Choi JH, et al. 2010. Clinical efficacy of direct DNA sequencing analysis on sputum specimens for early detection of drug-resistant Mycobacterium tuberculosis in a clinical setting. Chest 137:393-400.
10. CLSI. 2008. Laboratory detection and identification of mycobacteria: approved guideline. CLSI document M48-A. Clinical and Laboratory Standards Institute, Wayne, PA.
11. Cole ST, Davis Eisenach K, McMurray DN, Jacobs WR, Jr. 2005. Tuberculosis and the tubercle bacillus. ASM Press, Washington, DC.
12. de Kantor IN, LoBue PA, Thoen CO. 2010. Human tuberculosis caused by Mycobacterium bovis in the United States, Latin America and the Caribbean. Int. J. Tuberc. Lung Dis. 14:1369-1373.
13. Evans JT, et al. 2007. Cluster of human tuberculosis caused by Mycobacterium bovis: evidence for person-to-person transmission in the UK. Lancet 369:1270-1276. (Pubitemid 46552049)
14. Guerrero A, et al. 1997. Nosocomial transmission of Mycobacterium bovis resistant to 11 drugs in people with advanced HIV-1 infection. Lancet 350:1738-1742. (Pubitemid 28036673)
15. Hall TA. 1999. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symp. Ser. 41:95-98.
16. Halse TA, et al. 2010. Combined real-time PCR and rpoB gene pyrosequencing for rapid identification of Mycobacterium tuberculosis and determination of rifampin resistance directly in clinical specimens. J. Clin. Microbiol. 48:1182-1188.
17. Heep M, et al. 2001. Frequency of rpoB mutations inside and outside the cluster I region in rifampin-resistant clinical Mycobacterium tuberculosis isolates. J. Clin. Microbiol. 39:107-110. (Pubitemid 32059577)
18. Helb D, et al. 2010. Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology. J. Clin. Microbiol. 48:229-237.
19. Hirano K, Takahashi M, Kazumi Y, Fukasawa Y, Abe C. 1997. Mutation in pncA is a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis. Tuberc. Lung Dis. 78:117-122. (Pubitemid 28080549)
20. Hlavsa MC, et al. 2008. Human tuberculosis due to Mycobacterium bovis in the United States, 1995-2005. Clin. Infect. Dis. 47:168-175. (Pubitemid 351920616)
21. Horsburgh CR, Jr, et al. 1991. Survival of patients with acquired immune deficiency syndrome and disseminated Mycobacterium avium complex infection with and without antimycobacterial chemotherapy. Am. Rev. Respir. Dis. 144:557-559.
22. Isfahani BN, Tavakoli A, Salehi M, Tazhibi M. 2006. Detection of rifampin resistance patterns in Mycobacterium tuberculosis strains isolated in Iran by polymerase chain reaction-single-strand conformation polymorphism and direct sequencing methods. Mem. Inst. Oswaldo Cruz 101:597-602. (Pubitemid 44555603)
23. Job CK, Jayakumar J, Kearney M, Gillis TP. 2008. Transmission of leprosy: a study of skin and nasal secretions of household contacts of leprosy patients using PCR. Am. J. Trop. Med. Hyg. 78:518-521. (Pubitemid 351845207)
24. Jonmalung J, Prammananan T, Leechawengwongs M, Chaiprasert A. 2010. Surveillance of pyrazinamide susceptibility among multidrugresistant Mycobacterium tuberculosis isolates from Siriraj Hospital, Thailand. BMC Microbiol. 10:223.
25. Kalendar R, Lee D, Shulman AH. 2011. Java web tools for PCR, in silico PCR, and oligonucleotide assembly and analyses. Genomics 98:137-144.
26. Kapur V, et al. 1995. Rapid Mycobacterium species assignment and unambiguous identification of mutations associated with antimicrobial resistance in Mycobacterium tuberculosis by automated DNA sequencing. Arch. Pathol. Lab. Med. 119:131-138.
27. Kato-Maeda M, et al. 2011. Strain classification of Mycobacterium tuberculosis: congruence between large sequence polymorphisms and spoligotypes. Int. J. Tuberc. Lung Dis. 15:131-133.
28. Kato-Maeda M, Metcalfe JZ, Flores L. 2011. Genotyping of Mycobacterium tuberculosis: application in epidemiologic studies. Future Microbiol. 6:203-216.
29. Kent PT, Kubica GP. 1985. Public health mycobacteriology. U.S. Dept of Health and Human Services, Public Health Service, Centers for Disease Control, Atlanta, GA.
30. Lalvani A. 2007. Diagnosing tuberculosis infection in the 21st century: new tools to tackle an old enemy. Chest 131:1898-1906. (Pubitemid 46981652)
31. Lamm DL. 1992. Complications of bacillus Calmette-Guerin immunotherapy. Urol. Clin. North Am. 19:565-572.
32. Lebrun L, Mathieu D, Saulnier C, Nordmann P. 1997. Limits of commercial molecular tests for diagnosis of pulmonary tuberculosis. Eur. Respir. J. 10:1874-1876. (Pubitemid 27368385)
33. Leckie GW, et al. 1998. Method for reduction of inhibition in a Mycobacterium tuberculosis-specific ligase chain reaction DNA amplification assay. J. Clin. Microbiol. 36:764-767. (Pubitemid 28093263)
34. Lee AS, Teo AS, Wong SY. 2001. Novel mutations in ndh in isoniazidresistant Mycobacterium tuberculosis isolates. Antimicrob. Agents Chemother. 45:2157-2159. (Pubitemid 32591719)
35. LoBue PA, Betacourt W, Peter C, Moser KS. 2003. Epidemiology of Mycobacterium bovis disease in San Diego County, 1994-2000. Int. J. Tuberc. Lung Dis. 7:180-185. (Pubitemid 36172680)
36. LoBue PA, et al. 2004. Identification of a familial cluster of pulmonary Mycobacterium bovis disease. Int. J. Tuberc. Lung Dis. 8:1142-1146. (Pubitemid 39201264)
37. Lok KH, et al. 2002. Molecular differentiation of Mycobacterium tuberculosis strains without IS6110 insertions. Emerg. Infect. Dis. 8:1310-1313. (Pubitemid 35334707)
38. Markey B, Wan C, Hanger J, Phillips C, Timms P. 2007. Use of quantitative real-time PCR to monitor the shedding and treatment of chlamydiae in the koala (Phascolarctos cinereus). Vet. Microbiol. 120:334-342. (Pubitemid 46216667)
39. Martínez-Martínez L, Suarez AI, Winstanley J, Ortega MC, Bernard K. 1995. Phenotypic characteristics of 31 strains of Corynebacterium striatum isolated from clinical samples. J. Clin. Microbiol. 33:2458-2461.
40. McFarland, J. 1907. Nephelometer. JAMA 49:1176-1178.
41. McNabb A, Adie K, Rodrigues M, Black WA, Isaac-Renton J. 2006. Direct identification of mycobacteria in primary liquid detection media by partial sequencing of the 65-kilodalton heat shock protein gene. J. Clin. Microbiol. 44:60-66. (Pubitemid 43100580)
42. McNabb A, et al. 2004. Assessment of partial sequencing of the 65- kilodalton heat shock protein gene (hsp65) for routine identification of Mycobacterium species isolated from clinical sources. J. Clin. Microbiol. 42:3000-3011. (Pubitemid 38938049)
43. Negi SS, et al. 2009. Characterization of RPO B gene for detection of rifampicin drug resistance by SSCP and sequence analysis. Indian J. Med. Microbiol. 27:226-230.
44. Parsons LM, et al. 2002. Rapid and simple approach for identification of Mycobacterium tuberculosis complex isolates by PCR-based genomic deletion analysis. J. Clin. Microbiol. 40:2339-2345. (Pubitemid 34747330)
45. Patnaik M, Liegmann K, Peter JB. 2001. Rapid detection of smearnegative Mycobacterium tuberculosis by PCR and sequencing for rifampin resistance with DNA extracted directly from slides. J. Clin. Microbiol. 39:51-52. (Pubitemid 32059567)
46. Peloquin CA. 1993. Mycobacterial infections. Pharmacotherapy 13:634-639. (Pubitemid 23347038)
47. Piersimoni C, Scarparo C. 2008. Pulmonary infections associated with non-tuberculous mycobacteria in immunocompetent patients. Lancet Infect. Dis. 8:323-334. (Pubitemid 351615759)
48. Ramaswamy S, Musser JM. 1998. Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tuberc. Lung Dis. 79:3-29. (Pubitemid 29050434)
49. Ramaswamy SV, et al. 2003. Single nucleotide polymorphisms in genes associated with isoniazid resistance in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 47:1241-1250. (Pubitemid 36372035)
50. Rawls WH, et al. 1990. Fatal sepsis following intravesical bacillus Calmette-Guerin administration for bladder cancer. J. Urol. 144:1328-1330.
51. Rouillard JM, Zuker M, Gulari E. 2003. OligoArray 2.0: design of oligonucleotide probes for DNA microarrays using a thermodynamic approach. Nucleic Acids Res. 31:3057-3062. (Pubitemid 37441764)
52. Rouse DA, Morris SL. 1995. Molecular mechanisms of isoniazid resistance in Mycobacterium tuberculosis and Mycobacterium bovis. Infect. Immun. 63:1427-1433.
53. Rozen S, Skaletsky H. 2000. Primer3 on the WWW for general users and for biologist programmers. Methods Mol. Biol. 132:365-386.
54. Sandgren A, et al. 2009. Tuberculosis drug resistance mutation database. PLoS Med. 6:e2.
55. Scorpio A, Zhang Y. 1996. Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus. Nat. Med. 2:662-667. (Pubitemid 26191953)
56. Shamputa IC, Rigouts And L, Portaels F. 2004. Molecular genetic methods for diagnosis and antibiotic resistance detection of mycobacteria from clinical specimens. APMIS 112:728-752.
57. Siddiqi SH. 1989. Bactec TB system. Product and procedure manual. Revision B. Becton Dickinson Diagnostic Instruments System, Towson, MD.
58. Sreevatsan S, Pan X, Zhang Y, Kreiswirth BN, Musser JM. 1997. Mutations associated with pyrazinamide resistance in pncA of Mycobacterium tuberculosis complex organisms. Antimicrob. Agents Chemother. 41:636-640. (Pubitemid 27098417)
59. Telenti A, et al. 1997. Genotypic assessment of isoniazid and rifampin resistance in Mycobacterium tuberculosis: a blind study at reference laboratory level. J. Clin. Microbiol. 35:719-723. (Pubitemid 27083868)
60. Telenti A, et al. 1993. Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Lancet 341:647-650. (Pubitemid 23083244)
61. Thompson JD, Higgins DG, Gibson TJ. 1994. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22:4673-4680. (Pubitemid 24354800)
62. Tortoli E, et al. 2004. Proposal to elevate the genetic variant MAC-A, included in the Mycobacterium avium complex, to species rank as Mycobacterium chimaera sp. nov. Int. J. Syst. Evol. Microbiol. 54:1277-1285. (Pubitemid 39139851)
63. Traore H, van Deun A, Shamputa IC, Rigouts L, Portaels F. 2006. Direct detection of Mycobacterium tuberculosis complex DNA and rifampin resistance in clinical specimens from tuberculosis patients by line probe assay. J. Clin. Microbiol. 44:4384-4388. (Pubitemid 44937068)
64. Turenne CY, Tschetter L, Wolfe J, Kabani A. 2001. Necessity of quality-controlled 16S rRNA gene sequence databases: identifying nontuberculous Mycobacterium species. J. Clin. Microbiol. 39:3637-3648. (Pubitemid 32954514)
65. Warren RM, et al. 2006. Differentiation of Mycobacterium tuberculosis complex by PCR amplification of genomic regions of difference. Int. J. Tuberc. Lung Dis. 10:818-822. (Pubitemid 44031399)
66. Wayne LG, Krasnow I. 1966. Preparation of tuberculosis susceptibility testing mediums by means of impregnated disks. Tech Bull. Regist. Med. Technol. 36:115-117.
67. Weisburg WG, Barns SM, Pelletier DA, Lane DJ. 1991. 16S ribosomal DNA amplification for phylogenetic study. J. Bacteriol. 173:697-703.
68. Werle E, Schneider C, Renner M, Volker M, Fiehn W. 1994. Convenient single-step, one tube purification of PCR products for direct sequencing. Nucleic Acids Res. 22:4354-4355. (Pubitemid 24322750)
69. WHO. 2009. 2009 update, tuberculosis facts - Stop TB Partnership. World Health Organization, Geneva, Switzerland. http://www.stoptb.org/assets/ documents/resources/factsheets/tbfactsheet-2009update-one-page.pdf.
70. WHO. 2010. Fact sheet: multidrug and extensively drug-resistant TB (M/XTR-TB). 2010 Global report on surveillance and response. World Health Organization, Geneva, Switzerland. http://whqlibdoc.who.int/publications/2010/ 9789241599191-eng.pdf.
71. WHO. 2008. The top 10 causes of death. Fact sheet no. 310. World Health Organization, Geneva, Switzerland. http://www.who.int/mediacentre/factsheets/ fs310-2008.pdf.
72. Williams DL, et al. 1994. Characterization of rifampin-resistance in pathogenic mycobacteria. Antimicrob. Agents Chemother. 38:2380-2386.
73. Wilson KH, Blitchington RB, Greene RC. 1990. Amplification of bacterial 16S ribosomal DNA with polymerase chain reaction. J. Clin. Microbiol. 28:1942-1946. (Pubitemid 20260970)
74. Witjes JA, vd Meijden AP, Debruyne FM. 1990. Use of intravesical bacillus Calmette-Guerin in the treatment of superficial transitional cell carcinoma of the bladder: an overview. Urol. Int. 45:129-136.
75. Yang Z, et al. 2005. Simultaneous detection of isoniazid, rifampin, and ethambutol resistance of Mycobacterium tuberculosis by a single multiplex allele-specific polymerase chain reaction (PCR) assay. Diagn. Microbiol. Infect. Dis. 53:201-208. (Pubitemid 41607624)
76. Zhang Y, Heym B, Allen B, Young D, Cole S. 1992. The catalaseperoxidase gene and isoniazid resistance of Mycobacterium tuberculosis. Nature 358:591-593.